Myriad Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Myriad Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-723,373	Closed	-$120M	–	107
2019 Q3	$88.6M	Buy	723,373 +152,700	+27%	+$20.3M	9.09%	3
2019 Q2	$70.7M	Buy	+570,673	New	+$72.4M	6.62%	3
2019 Q1	–	Sell	-165,800	Closed	-$23.3M	–	103
2018 Q4	$23.3M	Buy	+165,800	New	+$22M	4.96%	5
2018 Q2	–	Sell	-15,200	Closed	-$2.55M	–	90
2018 Q1	$2.55M	Buy	+15,200	New	+$2.06M	0.23%	54
2017 Q4	–	Sell	-238,185	Closed	-$24.6M	–	93
2017 Q3	$24.6M	Sell	238,185 -147,400	-38%	-$11M	2.39%	12
2017 Q2	$17.4M	Buy	385,585 +54,900	+17%	+$2.16M	1.21%	21
2017 Q1	$12.1M	Buy	+330,685	New	+$12M	0.9%	30

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Myriad Asset Management's ONC Position: Q4 2019 in Review

Myriad Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2019, closing a stake of 723,373 shares — an estimated $120M sold.

Myriad Asset Management first reported a position in ONC in Q1 2017 and held it in 7 quarters. The position peaked at $88.6M in Q3 2019. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

Myriad Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2019 after selling out during the quarter.
Myriad Asset Management sold 723,373 BeOne Medicines Ltd shares in Q4 2019, an estimated $120M.
Myriad Asset Management first reported a position in BeOne Medicines Ltd in Q1 2017 and held it in 7 quarters.
Myriad Asset Management's BeOne Medicines Ltd position peaked at $88.6M in Q3 2019.
221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Myriad Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.